As immunotherapy moves beyond traditional PD-1/PD-L1 monotherapy, drug discovery faces new technical bottlenecks. Creative Biolabs addresses these shifts with custom antibody fragment engineering and multi-specific platforms to accelerate next-generation checkpoint pipelines.
The landscape of cancer immunotherapy is undergoing a major technological shift. While conventional monoclonal...
Driven by advances in immunology, precision medicine, and complement-targeted therapies, accurate functional complement activity analysis has become increasingly important for understanding immune regulation and accelerating therapeutic development..
The complement system plays a critical role in immune regulation, inflammation, and host defense, making it an increasingly important...
Traditional neuroscience models often struggle to replicate human brain complexity, limiting predictive accuracy and creating challenges for drug discovery and neurological disease research. Advanced 3D neural spheroids and brain-on-a-chip technologies are emerging as valuable platforms to improve biological relevance, accelerate innovation, and support next-generation neuroscience studies....
Despite rapid advances in regenerative medicine, iPSC generation remains a significant technical challenge due to challenges in efficiency, genomic integrity, and reproducibility. Discover how optimized viral and non-viral reprogramming strategies can help researchers overcome key barriers and accelerate stem cell research workflows.
Why iPSC Reprogramming Still Bottlenecks Stem Cell...
AAV vectors are transforming gene therapy, but manufacturing complexity, quality control demands, and delivery limitations remain major industry challenges. Discover how advanced AAV solutions help researchers improve reliability, scalability, and therapeutic development outcomes.
Addressing Key AAV Vector Challenges in Modern Gene Therapy
Gene therapy has entered a new era, with...
The cell therapy industry is moving toward more precise, scalable, and controllable immunotherapies. As researchers address challenges in CIK cell potency, consistency, and manufacturing complexity, Creative Biolabs provides advanced CIK development solutions supporting the future of cancer immunotherapy innovation.
The global cell therapy industry is entering a new stage of innovation,...
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek